All In Biotech

Drug Trial Radar · NCT05624749

Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)

A Randomized, Double-blind, Placebo-controlled Multicenter Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)

Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 288 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

288

Actual

Start

Apr 21, 2023

Primary completion

Apr 12, 2027

Study completion Apr 9, 2029

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Nov 22, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The trial will evaluate efficacy, safety and tolerability of ianalumab compared to placebo, given as monthly subcutaneous (s.c.) injection on top of standard-of-care (SoC) treatment in participants with active systemic lupus erythematosus (SLE).

Conditions

  • Systemic Lupus Erythematosus

Interventions

  • ianalumabDrug

    ianalumab s.c. monthly

  • placeboDrug

    placebo s.c. monthly

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants achieving Systemic Lupus Erythematosus Responder Index -4 (SRI-4)Time frame: Week 60

Locations

90 sites in 15 countries. Site status is shown where the registry gives one.

  • Pinnacle Research Group LLC

    Anniston, Alabama

  • Advanced Medical Research

    La Palma, California

  • University of California LA

    Los Angeles, California

  • Homestead Assoc In Research Inc

    Homestead, Florida

  • IRIS Research and Development

    Plantation, Florida

  • Emory University

    Atlanta, Georgia

  • Willow Rheumatology Wellness

    Willowbrook, Illinois

  • Bluegrass Community Research Inc

    Lexington, Kentucky

  • Accurate Clinical Research

    Lake Charles, Louisiana

  • UMC New Orleans

    New Orleans, Louisiana

  • University Of Maryland

    Baltimore, Maryland

  • Ahmed Arif Medical Research Center

    Grand Blanc, Michigan

  • Washington Univ School Of Medicine

    St Louis, Missouri

  • West Tennessee Research Institute

    Jackson, Tennessee

  • Novel Research LLC

    Bellaire, Texas

  • Novartis Investigative Site

    Caba, Argentina

  • Novartis Investigative Site

    Caba, Argentina

  • Novartis Investigative Site

    San Miguel de Tucumán, Argentina

  • Novartis Investigative Site

    La Plata, Buenos Aires, Argentina

  • Novartis Investigative Site

    Quilmes, Buenos Aires, Argentina

  • Novartis Investigative Site

    San Miguel, Buenos Aires, Argentina

  • Novartis Investigative Site

    San Miguel, Tucumán Province, Argentina

  • Novartis Investigative Site

    St Leonards, Australia

  • Novartis Investigative Site

    Maroochydore, Queensland, Australia

  • Novartis Investigative Site

    Concepción, Biobio, Chile

  • Novartis Investigative Site

    Valdivia, Los Ríos Region, Chile

  • Novartis Investigative Site

    Santiago, RM, Chile

  • Novartis Investigative Site

    Santiago, Santiago Metropolitan, Chile

  • Novartis Investigative Site

    Bogotá, Colombia

  • Novartis Investigative Site

    Medellín, Antioquia, Colombia

  • Novartis Investigative Site

    Barranquilla, Atlántico, Colombia

  • Novartis Investigative Site

    Barranquilla, Atlántico, Colombia

  • Novartis Investigative Site

    Chía, Cundinamarca, Colombia

  • Novartis Investigative Site

    Bucaramanga, Santander Department, Colombia

  • Novartis Investigative Site

    Cali, Valle del Cauca Department, Colombia

  • Novartis Investigative Site

    Montpellier, France

  • Novartis Investigative Site

    Paris, France

  • Novartis Investigative Site

    Paris, France

  • Novartis Investigative Site

    Paris, France

  • Novartis Investigative Site

    Toulouse, France

Showing 40 of 90 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.